selected publications
-
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality.
Blood advances.
2020
Academic Article
GET IT
Times cited: 95 -
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
Blood advances.
2020
Academic Article
GET IT
Times cited: 118 -
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2018
Academic Article
GET IT
Times cited: 219 -
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.
Blood cancer journal.
2018
Academic Article
GET IT
Times cited: 29 -
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia.
Blood.
2017
Academic Article
GET IT
Times cited: 117 - Learning from Waldenstrom Macroglobulinemia. Best practice & research. Clinical haematology. 2016 Editorial Article GET IT
-
Future therapeutic options for patients with Waldenström macroglobulinemia.
Best practice & research. Clinical haematology.
2016
Information Resource
GET IT
Times cited: 5 -
Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling.
Leukemia.
2016
Academic Article
GET IT
Times cited: 31 -
Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.
British journal of haematology.
2015
Academic Article
GET IT
Times cited: 81 -
Ibrutinib in previously treated Waldenström's macroglobulinemia.
The New England journal of medicine.
2015
Academic Article
GET IT
Times cited: 544 -
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.
The Lancet. Oncology.
2015
Academic Article
GET IT
Times cited: 152 -
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.
Leukemia.
2014
Article
GET IT
Times cited: 67 -
Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
PloS one.
2014
Academic Article
GET IT
Times cited: 11 -
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity.
The Journal of clinical investigation.
2013
Academic Article
GET IT
Times cited: 22 -
Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acid response element in the human thrombomodulin gene.
The Journal of biological chemistry.
1994
Academic Article
GET IT
Times cited: 41